magolibero
..se la sà gira..
non si deve schiodare da questi livelli finché non finiscono di moviemntarsele a botte da 2160pezzi alla volta ?
..
..
..
..
NicOx : Garufi ... e la Rivoluzione Pharma (5 lettori)
- Creatore Discussione Yesod
- Data di Inizio
- Stato
jenJEN
Mai domi!
NicOx to choice bank's goldman sachs for possible takeover offers
BIO SmartBrief | 02/13/2009
NicOx plans to get advice from goldman sachs to fend off unsolicited takeover proposals as it holds discussions with drug companies interested in its naproxcinod, an experimental pain medication. The French biotech firm received more partnership offers after the release of trial results showing that naproxcinod causes fewer adverse reactions than naproxen, a common painkiller, CEO Michele Garufi said. Bloomberg (02/13)
BIO SmartBrief | 02/13/2009
NicOx plans to get advice from goldman sachs to fend off unsolicited takeover proposals as it holds discussions with drug companies interested in its naproxcinod, an experimental pain medication. The French biotech firm received more partnership offers after the release of trial results showing that naproxcinod causes fewer adverse reactions than naproxen, a common painkiller, CEO Michele Garufi said. Bloomberg (02/13)
DickSIM
Prima o poi....ci becco!
jenJEN
Mai domi!
questa è una bufala...........
parola di dicksim!
Stavolta ti credo. Anche perchè la fonte è quel pazzo mitomane di Paxaloup!
Aeiou
▲ + 444%
Questa l'ho già sentita....
È che questa è la sua frase preferita!!
e a forza di ripeterla prima o poi ci imbrocca.
almeno speriamo!
Ultima modifica:
DickSIM
Prima o poi....ci becco!
e a forza di ripeterla prima o poi ci imbrocca.
le BOA nitriche sono nel mio dna......... appena posso non c'è la minima possibilità che mi esimi dal dovere di un vero cavaliere nitrico!!! giusto acquettina?
doctor NO
NO nel DNA
New Product Punctal System NicOx/Pfizer Auj. à 18:14
New Product Developments Punctal Plug Drug Delivery System NicOx/Pfizer's
Examine the Global Ophthalmic Market: Focus on Glaucoma
By: Business Wire | 21 Jan 2009 | 05:06 AM ET Text Size
NEW YORK, Jan 21, 2009 (BUSINESS WIRE) -- Reportlinker.com announces that a new market research report related to the Ophthalmic devices industry is available in its catalogue.
Global Ophthalmic Market: Focus on Glaucoma http://www.reportlinker.com/p099519/Global-Ophthalmic-Market-Focus-on-Glaucoma.html Glaucoma is a type of disease that causes an irreversible blindness, if it is left undetected or untreated. Moreover there is no cure for glaucoma and regular medication is the only way to prevent blindness. In fact this is one of the main issues in the treatment of glaucoma, regularity in taking a proper medication course. Most people are not able to take the complete medication and the rate of medication regimen non-compliance is very high.
Nearly half of the people who are being prescribed for medication discontinue only after six months due to various reasons. Another inherent characteristic of glaucoma and a deterrent in proper treatment is that most of the times this disease goes unnoticed.
The market for ophthalmology and glaucoma consists of prescription or treatment and surgical or detection devices. The prescription or pharmaceuticals market is comparatively larger than the devices market both for ophthalmic and glaucoma.
Contact Lenses is another significant market for ophthalmology. Region-wise US is the largest market for ophthalmic and glaucoma alike, and the global market is about 2-3 times that of the US market. Alcon, Allergan, Merck and Pfizer are main players.
The report focuses on glaucoma as a major ophthalmic market. The various aspects of glaucoma are discussed like glaucoma as a disease, types of glaucoma, and treatment of glaucoma. Global as well as US market size and forecasts are given for ophthalmic as well as glaucoma market. The market trends and the latest product developments in this field are also discussed. The major players operating in the market have also been profiled.
1. Glaucoma: An Introduction Types of Glaucoma Open-Angle Glaucoma Angle-Closure Glaucoma Glaucoma Tests Glaucoma Treatment Laser Treatment Surgical Treatment 2. Ophthalmic Market Size 2.1 Global Ophthalmic Market Market by Region Market Segments 2.2 US Ophthalmic Market Market Segments 2.3 Japanese Ophthalmic Market Growth Rate 3. Glaucoma Market Size 3.1 Global Glaucoma Market Market Value Market Share 3.2 US Glaucoma Market Market Value Market Share 4. Market Dynamics 4.1 Market Trends Growing Aging Population Irregularity in Adhering to Drug Treatment Unawareness about Suffering from Glaucoma 4.2 New Product Developments Punctal Plug Drug Delivery System NicOx/Pfizer's Glaucoma Drug Alcon's TRAVATANZ[TM] Approval in Japan Lexicon Pharmaceuticals Identifies New Drug Candidate Othera Pharmaceuticals Files Investigational New Drug 5. Company Profiles 5.1 Alcon Overview Business Strategies Reaching Out to Customers Globally Research Commitment to Ophthalmology 5.2 Allergan Overview Business Strategies Improving Operating Efficiency Diversity of Product Lines 5.3 Pfizer Overview Business Strategies Acquisitions, Licensing and Collaborations Cost Reduction Strategy 5.4 Merck & Co.
Overview Business Strategies Focus on Customer Needs Business Efficiency 6. Market Forecast Ophthalmic Market Forecast Glaucoma Market Forecast List of Tables Ophthalmic Market Segments Region-wise CAGR of Global Prescription Ophthalmic Market (2005-10E) Growth of Japanese Prescription Ophthalmic Market by Segments (2005-10E) List of Charts Types of Glaucoma Glaucoma Tests Global Prescription Ophthalmic Market by Region (2000/05/10E) Segment-wise Division of Regional Ophthalmic Market Global Ophthalmic Market by Segments (2006-07) US Ophthalmic Market by Segments (2004-2007) Japanese Prescription Ophthalmic Market by Segments (2005/10E) Global Glaucoma Market Size and Growth (2006-2008E) Market Share of Leading Market Players (2007) Glaucoma Market Share by Drug Types (2007) US Glaucoma Market Value (2006-0 Market Share of US Glaucoma Market (2007) Sales Growth of Alcon (2003-07) Sales Growth of Allergan (2003-07) Sales Growth of Pfizer (2003-07) Sales Growth of Merck (2003-07) Global Ophthalmic Market Forecast (2008E-10E) US Ophthalmic Market Forecast (2008-11E) Global Glaucoma Market Forecast (2009-12E) US Glaucoma Market Forecast (2009-12E) To order this report: Global Ophthalmic Market: Focus on Glaucoma http://www.reportlinker.com/p099519/Global-Ophthalmic-Market-Focus-on-Glaucoma.html More market research reports here! SOURCE: ReportLinker CONTACT: Reportlinker Nicolas: [email protected] US: (805)-652-2626 Intl: +1 805-652-2626 Copyright Business Wire 2009 -0- INDUSTRY KEYWORD: Health Optical
lien : http://www.cnbc.com/id/28768406/site/14081545
New Product Developments Punctal Plug Drug Delivery System NicOx/Pfizer's
Examine the Global Ophthalmic Market: Focus on Glaucoma
By: Business Wire | 21 Jan 2009 | 05:06 AM ET Text Size
NEW YORK, Jan 21, 2009 (BUSINESS WIRE) -- Reportlinker.com announces that a new market research report related to the Ophthalmic devices industry is available in its catalogue.
Global Ophthalmic Market: Focus on Glaucoma http://www.reportlinker.com/p099519/Global-Ophthalmic-Market-Focus-on-Glaucoma.html Glaucoma is a type of disease that causes an irreversible blindness, if it is left undetected or untreated. Moreover there is no cure for glaucoma and regular medication is the only way to prevent blindness. In fact this is one of the main issues in the treatment of glaucoma, regularity in taking a proper medication course. Most people are not able to take the complete medication and the rate of medication regimen non-compliance is very high.
Nearly half of the people who are being prescribed for medication discontinue only after six months due to various reasons. Another inherent characteristic of glaucoma and a deterrent in proper treatment is that most of the times this disease goes unnoticed.
The market for ophthalmology and glaucoma consists of prescription or treatment and surgical or detection devices. The prescription or pharmaceuticals market is comparatively larger than the devices market both for ophthalmic and glaucoma.
Contact Lenses is another significant market for ophthalmology. Region-wise US is the largest market for ophthalmic and glaucoma alike, and the global market is about 2-3 times that of the US market. Alcon, Allergan, Merck and Pfizer are main players.
The report focuses on glaucoma as a major ophthalmic market. The various aspects of glaucoma are discussed like glaucoma as a disease, types of glaucoma, and treatment of glaucoma. Global as well as US market size and forecasts are given for ophthalmic as well as glaucoma market. The market trends and the latest product developments in this field are also discussed. The major players operating in the market have also been profiled.
1. Glaucoma: An Introduction Types of Glaucoma Open-Angle Glaucoma Angle-Closure Glaucoma Glaucoma Tests Glaucoma Treatment Laser Treatment Surgical Treatment 2. Ophthalmic Market Size 2.1 Global Ophthalmic Market Market by Region Market Segments 2.2 US Ophthalmic Market Market Segments 2.3 Japanese Ophthalmic Market Growth Rate 3. Glaucoma Market Size 3.1 Global Glaucoma Market Market Value Market Share 3.2 US Glaucoma Market Market Value Market Share 4. Market Dynamics 4.1 Market Trends Growing Aging Population Irregularity in Adhering to Drug Treatment Unawareness about Suffering from Glaucoma 4.2 New Product Developments Punctal Plug Drug Delivery System NicOx/Pfizer's Glaucoma Drug Alcon's TRAVATANZ[TM] Approval in Japan Lexicon Pharmaceuticals Identifies New Drug Candidate Othera Pharmaceuticals Files Investigational New Drug 5. Company Profiles 5.1 Alcon Overview Business Strategies Reaching Out to Customers Globally Research Commitment to Ophthalmology 5.2 Allergan Overview Business Strategies Improving Operating Efficiency Diversity of Product Lines 5.3 Pfizer Overview Business Strategies Acquisitions, Licensing and Collaborations Cost Reduction Strategy 5.4 Merck & Co.
Overview Business Strategies Focus on Customer Needs Business Efficiency 6. Market Forecast Ophthalmic Market Forecast Glaucoma Market Forecast List of Tables Ophthalmic Market Segments Region-wise CAGR of Global Prescription Ophthalmic Market (2005-10E) Growth of Japanese Prescription Ophthalmic Market by Segments (2005-10E) List of Charts Types of Glaucoma Glaucoma Tests Global Prescription Ophthalmic Market by Region (2000/05/10E) Segment-wise Division of Regional Ophthalmic Market Global Ophthalmic Market by Segments (2006-07) US Ophthalmic Market by Segments (2004-2007) Japanese Prescription Ophthalmic Market by Segments (2005/10E) Global Glaucoma Market Size and Growth (2006-2008E) Market Share of Leading Market Players (2007) Glaucoma Market Share by Drug Types (2007) US Glaucoma Market Value (2006-0 Market Share of US Glaucoma Market (2007) Sales Growth of Alcon (2003-07) Sales Growth of Allergan (2003-07) Sales Growth of Pfizer (2003-07) Sales Growth of Merck (2003-07) Global Ophthalmic Market Forecast (2008E-10E) US Ophthalmic Market Forecast (2008-11E) Global Glaucoma Market Forecast (2009-12E) US Glaucoma Market Forecast (2009-12E) To order this report: Global Ophthalmic Market: Focus on Glaucoma http://www.reportlinker.com/p099519/Global-Ophthalmic-Market-Focus-on-Glaucoma.html More market research reports here! SOURCE: ReportLinker CONTACT: Reportlinker Nicolas: [email protected] US: (805)-652-2626 Intl: +1 805-652-2626 Copyright Business Wire 2009 -0- INDUSTRY KEYWORD: Health Optical
lien : http://www.cnbc.com/id/28768406/site/14081545
acqua+
ONDA NITRICA
giusto acquettina?
parli come un VERO cavaliere Nitrico
approposito ,,,, l'AT cosa dice ????
,,, e l'oroscopo ???
DickSIM
Prima o poi....ci becco!
parli come un VERO cavaliere Nitrico
approposito ,,,, l'AT cosa dice ????
,,, e l'oroscopo ???
sai che l'AT è ciuffa...........
io mi baso solo sugli oroscopi........che hanno sempre guidato la mia mano!
quindi >>>>>>>>> per lunedi, per quelli nati sotto il segno nitrico...
con pesci in saturno e la vergine avvinghiata ai gemelli è prevista una giornata alquanto interessante........ in amore...okkio alle soprese
sul lavoro....la collega ti può importunare
denaro...... se puoi ,sfrutta le BOA
- Stato